Catalyst Wire Dossier Catalyst Wire Dossier

ADX-850

· ADARx Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADX-850, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension [Phase 1]

See pricing